NCT03704922View on ClinicalTrials.gov

Age of Blood in Sickle Cell Transfusion

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 4, 2017

Primary Completion Date

January 11, 2024

Study Completion Date

January 11, 2024

Conditions
Sickle Cell Disease
Interventions
BIOLOGICAL

Transfusion

Red cell units for transfusion

Trial Locations (3)

27599

University of North Carolina at Chapel Hill, Chapel Hill

30322

Emory University, Atlanta

53226

Versiti Wisconsin, Milwaukee

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT03704922 - Age of Blood in Sickle Cell Transfusion | Biotech Hunter | Biotech Hunter